We are live on ! Find out more
1CM

1492 Capital Management Portfolio holdings

AUM $263M
1-Year Est. Return 61.9%
This Fund
S&P 500
This Quarter Est. Return
+9.27%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$162M
AUM Growth
+$7.03M
Cap. Flow
+$1.02M
Cap. Flow %
0.63%
Top 10 Hldgs %
31.65%
Holding
122
New
18
Increased
23
Reduced
42
Closed
17

Sector Composition

Rank Sector Weight
1 Healthcare 26.21%
2 Technology 21.32%
3 Industrials 14.5%
4 Consumer Discretionary 9.54%
5 Communication Services 7.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PERI icon
1
Perion Network
PERI
$367M
$7.48M 4.62%
189,049
-221
-0.1% -$7.36K
ZETA icon
2
Zeta Global
ZETA
$4.77B
$5.72M 3.53%
527,936
+32,959
+7% +$317K
CPA icon
3
Copa Holdings
CPA
$5.56B
$5.48M 3.38%
59,367
-77
-0.1% -$6.99K
DCGO icon
4
DocGo
DCGO
$58.9M
$5.48M 3.38%
633,561
-740
-0.1% -$6.53K
STRL icon
5
Sterling Infrastructure
STRL
$20.3B
$5.14M 3.17%
135,773
-149
-0.1% -$5.44K
EXAS
6
DELISTED
Exact Sciences
EXAS
$5.04M 3.11%
74,302
+23,527
+46% +$1.51M
SMAR
7
DELISTED
Smartsheet Inc.
SMAR
$4.81M 2.96%
100,560
+84,077
+510% +$3.66M
QDEL icon
8
QuidelOrtho
QDEL
$1.09B
$4.36M 2.69%
48,975
+6,235
+15% +$542K
CRS icon
9
Carpenter Technology
CRS
$30B
$3.92M 2.42%
87,493
-16,030
-15% -$730K
MXL icon
10
MaxLinear
MXL
$6.49B
$3.88M 2.39%
109,748
+929
+0.9% +$33.7K
TNDM icon
11
Tandem Diabetes Care
TNDM
$1.17B
$3.86M 2.38%
95,155
+80,584
+553% +$3.34M
PCRX icon
12
Pacira BioSciences
PCRX
$1.02B
$3.73M 2.3%
91,283
+75,130
+465% +$2.99M
DAR icon
13
Darling Ingredients
DAR
$9.93B
$3.64M 2.25%
62,401
-110
-0.2% -$6.92K
PWSC
14
DELISTED
PowerSchool Holdings, Inc.
PWSC
$3.58M 2.21%
180,408
+97,216
+117% +$2.13M
ACEL icon
15
Accel Entertainment
ACEL
$979M
$3.56M 2.2%
391,172
-142
-0% -$1.28K
SM icon
16
SM Energy
SM
$7.96B
$3.53M 2.18%
125,222
+18,942
+18% +$578K
CZR icon
17
Caesars Entertainment
CZR
$6.1B
$3.22M 1.98%
65,886
+55
+0.1% +$2.7K
RNG icon
18
RingCentral
RNG
$4.05B
$3.18M 1.96%
103,615
+45,411
+78% +$1.62M
LTHM
19
DELISTED
Livent Corporation
LTHM
$3.14M 1.94%
144,454
-174
-0.1% -$4.02K
ADTN icon
20
Adtran
ADTN
$798M
$2.73M 1.69%
172,248
-33,411
-16% -$580K
CADE
21
DELISTED
Cadence Bank
CADE
$2.71M 1.67%
130,552
+72,336
+124% +$1.8M
ARQT icon
22
Arcutis Biotherapeutics
ARQT
$3.42B
$2.46M 1.52%
223,516
+48,970
+28% +$708K
SHYF
23
DELISTED
The Shyft Group
SHYF
$2.27M 1.4%
99,682
+70,515
+242% +$1.98M
MNKD icon
24
MannKind Corp
MNKD
$1.28B
$2.2M 1.36%
536,725
-1,105
-0.2% -$5.33K
CACI icon
25
CACI
CACI
$10.8B
$2.18M 1.35%
7,360
-11
-0.1% -$3.24K

Similar funds

1492 Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, 1492 Capital Management held 122 positions worth $162M, up 4.5% from $155M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

1492 Capital Management's Q1 2023 filing shows 18 new, 23 increased, 42 reduced and 17 closed positions. Its largest new stake was Pinnacle Financial Partners Inc: 37,163 shares worth $2.05M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $13.5M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 29% a quarter earlier, followed by Technology and Industrials.

  • 1492 Capital Management's largest Q1 2023 buy was Pinnacle Financial Partners Inc: 37,163 shares worth $2.05M.
  • 1492 Capital Management added most to Smartsheet Inc. in Q1 2023, an estimated $3.66M increase.
  • 1492 Capital Management's biggest Q1 2023 reduction was Ranger Oil Corporation Class A Common Stock, cutting an estimated $3.98M.
  • 1492 Capital Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, selling an estimated $13.5M.
  • 1492 Capital Management's ten largest holdings make up 32% of its $162M portfolio in Q1 2023.
  • 1492 Capital Management opened 18 new positions and closed 17 in Q1 2023.
  • 1492 Capital Management's portfolio value rose 4.5% quarter-over-quarter to $162M.

Based on 1492 Capital Management's 13F filing for Q1 2023, filed 12 May 2023.